ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007

Harkin, Bumpers Concerned Over Centers Funding

May 5, 1989

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986